These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 32126476)
21. Postictal ammonia as a biomarker for electrographic convulsive seizures: A prospective study. Albadareen R; Gronseth G; Landazuri P; He J; Hammond N; Uysal U Epilepsia; 2016 Aug; 57(8):1221-7. PubMed ID: 27245120 [TBL] [Abstract][Full Text] [Related]
22. Postictal generalized EEG suppression after generalized convulsive seizures: A double-edged sword. Xu J; Jin B; Yan J; Wang J; Hu J; Wang Z; Chen Z; Ding M; Chen S; Wang S Clin Neurophysiol; 2016 Apr; 127(4):2078-84. PubMed ID: 26851982 [TBL] [Abstract][Full Text] [Related]
23. Risk factors of postictal generalized EEG suppression in generalized convulsive seizures. Alexandre V; Mercedes B; Valton L; Maillard L; Bartolomei F; Szurhaj W; Hirsch E; Marchal C; Chassoux F; Petit J; Crespel A; Nica A; Navarro V; Kahane P; De Toffol B; Thomas P; Rosenberg S; Denuelle M; Jonas J; Ryvlin P; Rheims S; Neurology; 2015 Nov; 85(18):1598-603. PubMed ID: 26333799 [TBL] [Abstract][Full Text] [Related]
24. High Mobility Group Protein B1 (HMGB1) and Interleukin-1β as Prognostic Biomarkers of Epilepsy in Children. Zhu M; Chen J; Guo H; Ding L; Zhang Y; Xu Y J Child Neurol; 2018 Dec; 33(14):909-917. PubMed ID: 30303442 [TBL] [Abstract][Full Text] [Related]
25. Correlation of MMP-9 and HMGB1 expression with the cognitive function in patients with epilepsy and factors affecting the prognosis. Huang Q; Liu J; Shi Z; Zhu X Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):39-47. PubMed ID: 32538745 [TBL] [Abstract][Full Text] [Related]
26. The Role of High Mobility Group Box-1 in Epileptogenesis. Fu L; Nishibori M Acta Med Okayama; 2019 Oct; 73(5):383-386. PubMed ID: 31649363 [TBL] [Abstract][Full Text] [Related]
28. HMGB1 contributes to the irradiation-induced endothelial barrier injury through receptor for advanced glycation endproducts (RAGE). Zhou H; Jin C; Cui L; Xing H; Liu J; Liao W; Liao H; Yu Y J Cell Physiol; 2018 Sep; 233(9):6714-6721. PubMed ID: 29215715 [TBL] [Abstract][Full Text] [Related]
29. Impact of treatment on blood-brain barrier impairment in Wilson's disease. Misztal M; Członkowska A; Cudna A; Palejko A; Litwin T; Piechal A; Kurkowska-Jastrzębska I Neurol Neurochir Pol; 2023; 57(4):379-386. PubMed ID: 37526174 [TBL] [Abstract][Full Text] [Related]
30. High-mobility-group box protein 1A box reduces development of sodium laurate-induced thromboangiitis obliterans in rats. Kong X; Yuan H; Wu X; Zhang J; Zhou H; Wang M; Liu Y; Jin X J Vasc Surg; 2013 Jan; 57(1):194-204. PubMed ID: 23069071 [TBL] [Abstract][Full Text] [Related]
31. Immunogenic cell death biomarkers HMGB1, RAGE, and DNAse indicate response to radioembolization therapy and prognosis in colorectal cancer patients. Fahmueller YN; Nagel D; Hoffmann RT; Tatsch K; Jakobs T; Stieber P; Holdenrieder S Int J Cancer; 2013 May; 132(10):2349-58. PubMed ID: 23047645 [TBL] [Abstract][Full Text] [Related]
33. Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure. Basta G; Del Turco S; Navarra T; Lee WM; Liver Transpl; 2015 Jun; 21(6):847-54. PubMed ID: 25825217 [TBL] [Abstract][Full Text] [Related]
34. The incidence of peri-ictal prone position in patients with generalized convulsive seizures. Wang S; Graf S; Xu J; Issa NP; Ali A; Rose S; Wu S; Jacobsen J; Warnke P; Tao JX Epilepsy Behav; 2016 Aug; 61():158-161. PubMed ID: 27351726 [TBL] [Abstract][Full Text] [Related]
35. [Changes in serum high mobility group box-1 protein and high-sensitivity C-reactive protein in patients with acute cerebral infarction and their clinical significance]. Zhou P; Li YQ; Li WD; Han TS; Yang SJ; Yao YM; Zhang YY; Yu Y Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 May; 24(5):265-8. PubMed ID: 22587919 [TBL] [Abstract][Full Text] [Related]
36. Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy. Pauletti A; Terrone G; Shekh-Ahmad T; Salamone A; Ravizza T; Rizzi M; Pastore A; Pascente R; Liang LP; Villa BR; Balosso S; Abramov AY; van Vliet EA; Del Giudice E; Aronica E; Antoine DJ; Patel M; Walker MC; Vezzani A Brain; 2017 Jul; 140(7):1885-1899. PubMed ID: 28575153 [TBL] [Abstract][Full Text] [Related]
37. Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsy. Walker LE; Frigerio F; Ravizza T; Ricci E; Tse K; Jenkins RE; Sills GJ; Jorgensen A; Porcu L; Thippeswamy T; Alapirtti T; Peltola J; Brodie MJ; Park BK; Marson AG; Antoine DJ; Vezzani A; Pirmohamed M J Clin Invest; 2017 Jun; 127(6):2118-2132. PubMed ID: 28504645 [TBL] [Abstract][Full Text] [Related]
38. Receptor for Advanced Glycation Endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures. Iori V; Maroso M; Rizzi M; Iyer AM; Vertemara R; Carli M; Agresti A; Antonelli A; Bianchi ME; Aronica E; Ravizza T; Vezzani A Neurobiol Dis; 2013 Oct; 58():102-14. PubMed ID: 23523633 [TBL] [Abstract][Full Text] [Related]
39. Inhibiting HMGB1-RAGE axis prevents pro-inflammatory macrophages/microglia polarization and affords neuroprotection after spinal cord injury. Fan H; Tang HB; Chen Z; Wang HQ; Zhang L; Jiang Y; Li T; Yang CF; Wang XY; Li X; Wu SX; Zhang GL J Neuroinflammation; 2020 Oct; 17(1):295. PubMed ID: 33036632 [TBL] [Abstract][Full Text] [Related]
40. Role of Receptors for Advanced Glycation End Products and High-Mobility Group Box 1 in the Outcome of Human T Cell Lymphotropic Type 1 Infection. Yaghouti N; Boostani R; Mohamamdi A; Poursina Z; Rezaee SA; Vakili V; Valizadeh N; Shams A; Rafatpanah H Viral Immunol; 2019 Mar; 32(2):89-94. PubMed ID: 30585773 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]